{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-097705","form_type":"8-K","ticker":"ADTX","cik":"0001726711","company_name":"Aditxt, Inc.","filed_at":"2023-12-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.202777+00:00","generated_at":"2026-06-07T09:12:05.322860+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Aditxt enters asset purchase agreement to acquire MDNA's early cancer detection platform","bullets":["Pearsanta to acquire MDNA's early cancer detection IP for $1M cash + 50K Aditxt shares + warrants + Pearsanta preferred valued up to $25M.","Closing requires Aditxt/Pearsanta to raise at least $10M in debt or equity financing.","MDNA can terminate if Aditxt fails to pay $500K upfront working capital by December 31, 2023.","Pearsanta preferred shares designed to provide as-converted value of $25M; additional shares if shortfall.","Warrants for 50K Aditxt shares exercisable at closing price for 5 years."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-097705","json":"https://secwatch.observer/filing/0001213900-23-097705.json","markdown":"https://secwatch.observer/filing/0001213900-23-097705.md","text":"https://secwatch.observer/filing/0001213900-23-097705.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1726711/000121390023097705/0001213900-23-097705-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1726711/000121390023097705/ea190477-8k_aditxtinc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T09:12:05.322860+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7efcaf8df2e558ef099bb7fa9544689d2ebd0dac","claim":"Aditxt, Inc. entered into Purchase Agreement with MDNA Life Sciences, Inc. (effective 2023-12-17).","evidence_excerpt":"On December 17, 2023, Aditxt, Inc., a Delaware corporation (the “ Company ”) entered into an Asset Purchase Agreement (the “ Purchase Agreement ”) with Pearsanta, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ Pearsanta ”) and MDNA Life Sciences, Inc., a Delaware corporation (“ MDNA ”), pursuant to which Pearsanta will acquire certain intellectual property and other specified assets relating to MDNA’s early cancer detection platform.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390023097705/0001213900-23-097705-index.htm","confidence":0.97,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"MDNA Life Sciences, Inc."},{"label":"Effective","value":"2023-12-17"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}